An overview of requirements for the marketing-authorisation holder
Session 5: Pharmacovigilance
Pre- and post-authorisation regulatory support for SMEs
Speaker: Priya Bahri, Scientific Administrator, Coordination and Networking, EMA
Видео An overview of requirements for the marketing-authorisation holder канала emainfo
Pre- and post-authorisation regulatory support for SMEs
Speaker: Priya Bahri, Scientific Administrator, Coordination and Networking, EMA
Видео An overview of requirements for the marketing-authorisation holder канала emainfo
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
1.Overview of the EMA and the centralised procedure
EV-M5b EVDAS training for Marketing Authorisation Holders
Introduction and Overview of applications for marketing authorisation
Wie werden eigentlich Arzneimittel entwickelt?
Impact of Brexit on veterinary applications/ marketing authorisations
Maintenance of information on authorised medicines by marketing authorisation holders ('Art. 57')
Quality aspects in investigational medicinal product developments
5. Pharmacovigilance
Marketing Authorisation in EU| European Medicines Agency (EMA)| MRP, DCP, CP & National Procedure
The EMA perspective on drug approval process in the era of precision medicine
An introduction to european market access
Working for every patient in Europe
Pharmacovigilance Interview Questions and Answers
How does EMA support SMEs? (FR)
Characterizing FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
Digital Innovation in Pharma Marketing | Dorothy Czylyski, Head of Health at No Fixed Address Inc.
How does EMA support SMEs? (PL)
Pharma Marketing: Regulatory & Compliance- Reconnecting Ethics, Courage & Commercial Sense
Lifecycle Approach to API Process Validation
Electronic Orange Book